CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +3,144 | $136.18 | $428K | 1,404,228 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +311 | $136.91 | $43K | 154,189 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +3,693 | $136.91 | $506K | 1,407,921 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +390 | $137.69 | $54K | 154,579 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +4,631 | $137.69 | $638K | 1,412,552 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +427 | $140.90 | $60K | 155,006 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +5,072 | $140.90 | $715K | 1,417,624 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +910 | $141.45 | $129K | 155,916 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +10,790 | $141.45 | $1.5M | 1,428,414 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +109 | $142.86 | $16K | 156,025 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +1,291 | $142.86 | $184K | 1,429,705 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +537 | $145.46 | $78K | 156,562 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +6,369 | $145.46 | $926K | 1,436,074 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +252 | $145.98 | $37K | 156,814 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +2,994 | $145.98 | $437K | 1,439,068 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +2,228 | $146.21 | $326K | 159,042 |
| 2023-11-13 | BAKER BROS. ADVISORS LP Director | Purchase | +26,426 | $146.21 | $3.9M | 1,465,494 |
| 2023-10-03 | BAKER BROS. ADVISORS LP Director | Purchase · Common Stock Warrant (right to buy) | +125,447 | $151.69 | $19.0M | 125,447 |
| 2023-10-03 | BAKER BROS. ADVISORS LP Director | Purchase · Common Stock Warrant (right to buy) | +1,522,651 | $151.69 | $231.0M | 1,522,651 |
| 2023-09-11 | Sibold William John President and CEO | Grant or award | +50,000 | 50,000 |
Page 46 of 82 · 1,629 trades